Approved Uses for Sildenafil Citrate Medication

operations, noted in a separate interview. “Prescribers can offer an injectable form or an oral form of the same semaglutide Ozempic brand that they know of,” he said, “and consumers have flexibility and optionality between an injectable form and an oral form, and that concordance is very helpful, just from an awareness, branding and recognition perspective.”In parallel, the company is offering the new pill through some 70,000 brick-and-mortar pharmacies, and additionally, Novo is manufacturing the new Ozempic format end-to-end in the United States, largely through investments in its North Carolina operations, Millar said.With the context of supply constraints that hampered both Novo’s and Lilly’s early GLP-1 launches, Millar stressed that Novo feels “very confident in our ability to securely and reliably, dependably supply the U.S. marketplace, both with the Ozempic pill and Wegovy pill.” Rybelsus will now be discontinued as a brand across the U.S., with Ozempic pill branding and campaigns taking over. “That rebranding will be approached over the year,” Cinca said, “We will now start making more introductions for the Ozempic pill being available and for the broader brand that you can now get Ozempic as a pen or a pill.”As Novo sunsets Rybelsus, Cinca also believes this rebranding could help boost scripts of the pill. “We do anticipate this will have great resonance with our customers because we know many patients prefer a pill over a pen. Now they can be on a branded pill that is a GLP-1, and now that is Ozempic pill.” The Wegovy brand will not change except for the addition of the Wegovy pill, announced at the start of the year, in addition to Wegovy injection. This comes amid a major new franchise in tirzepatide from Novo’s longtime rival El Lilly, a dual GIP and GLP-1 receptor agonist for diabetes and obesity under the brand names Mounjaro and Zepbound, both of which are rivaling Novo’s sales and branding iconography. Lilly also recently launched its newly approved GLP-1 drug Foundayo in the U.S., made from the ingredient orforglipron. This becomes a new direct rival for Wegovy pill.These latest changes to the Ozempic are U.S.-only: The Rybelsus branding will continue to exist outside of the country. As the drug is also being made and sold solely in the U.S. in this form and branding, Cinca said the message is that this is “made in America for Americans.” Rybelsus made history as the first GLP-1 drug to come in a tablet form when it was approved by the FDA in 2019.

MeSH terms

Built on scientific rigor and developed by the same team behind Viagra® and Cialis®, Vella addresses critical gaps in women's health research with products designed to empower women through education and evidence-based care. The company launched the category-first Vella Pleasure Serum, giving women unprecedented agency over their sexual experiences through a science-backed, hormone-free approach. MEDIA CONTACT: [email protected] SOURCE Vella Bioscience 21% more press release views with Request a Demo Boost your research with our translational medicine data. Boost your decision using our deal data. Boost your research with our Core Patent data.

Medications & Supplements

Identify the latest clinical trials across global registries. Accelerate your research with the latest regulatory approval information. Understand key drug designations in just a few clicks with Synapse. Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals. Synapse data is also accessible to external entities via APIs or data packages. Current Rybelsus patients “should continue their medication as directed,” Novo said in a statement, but “speak with their healthcare professionals about transitioning to the Ozempic pill, as appropriate.”The changeup was first announced in February, but the new pill will officially start rolling out Monday, May 4.

Grounded in female arousal physiology, Vella's hero clinical‑grade arousal serum applies a more precise, performance‑led approach to CBD in intimate wellness NEW YORK, April 14, 2026 /PRNewswire/ -- Though conversations around women's pleasure are slowly opening up, the gap between awareness and access remains. Most "solutions" designed to support the full continuum of desire, arousal, and pleasure - particularly amid hormonal change - have yet to catch up. Dialogue alone is not enough: women need real, reliable solutions that support the full continuum of desire, arousal, and pleasure.

Brand names

This localized delivery supports vasodilation and sensory responsiveness: two important physiological components of arousal. Nano-encapsulated CBD isolate is delivered to the smooth muscle beneath the skin, a critical but often overlooked aspect of arousal. By supporting healthy blood flow and relaxing this tissue, Pleasurewave helps restore the body's natural rhythm of sensation Free from sildenafil 50 mg tab cooling agents or numbing effects, the formula includes Vitamin E to soothe sensitive skin, monk fruit extract for antioxidant support, and a clean, oil-free, microbiome-friendly base designed for compatibility with condoms, toys, and daily intimacy. In clinical studies, 90% of participants reported improvement in at least one aspect of sexual pleasure, particularly among women navigating perimenopause, menopause, stress, or other hormonal shifts. "Pleasurewave plays a central role within the broader Vella portfolio," said Joy Allen-Altimare, President of Vella Bioscience.

Off-label use for Viagra

"It was designed to support a critical moment in a woman's experience when desire may be present, but the body needs assistance to respond. By offering targeted, reliable arousal support, Pleasurewave helps create greater confidence, connection, and ease in intimate experiences." Vella's Pleasurewave is available at select premium retailers such as Lemon Laine, Cos Bar, Amazon and at . About Vella Bioscience, Inc. Vella Bioscience, Inc. is a female health innovator dedicated to advancing women's sexual, hormonal, and intimate wellness through rigorous science and proprietary biotechnology. This is where Vella Bioscience, the pioneering female health company built to address long-overlooked gaps in women's sildenafil film tablet sexual wellness, has focused its work. At the core of this mission is Pleasurewave™, Vella's first clinical-grade arousal serum, which applies a precise, biology-led approach to CBD to support the physiological realities of female pleasure. Continue Reading Vella Bioscience's Pleasurewave As CBD has become increasingly associated with intimacy, particularly among women navigating hormonal transition, Vella uses a science-led approach grounded in biological intent, formulation discipline, and transparency over trend.

CBD is often discussed as a single ingredient, yet its form and composition vary widely. Full-spectrum extracts can fluctuate significantly in CBD concentration and include secondary compounds without consistent purpose. Pleasurewave is formulated using CBD isolate, a highly purified form of cannabidiol processed to remove all other cannabinoids, plant material, waxes, and terpenes, leaving behind only pure CBD.

• Some users report headaches and dizziness after taking sildenafil.
• A common side effect is facial flushing and nasal congestion.
• Rare side effects include sudden hearing loss or vision loss.
• Priapism requires urgent medical attention to prevent tissue damage.
• Sudden vision loss should be immediately evaluated by a doctor.
• Allergic reactions such as rash, hives, or swelling are possible.
• Discontinue use and seek medical help if serious side effects occur.

This allows Vella to formulate with greater consistency and control. "We're at a moment where women are finally being invited into the conversation around pleasure, but they're still being underserved when it comes to solutions," said Carolyn Wheeler, Co-Founder and CEO of Vella Bioscience. "Pleasurewave was created to close that gap by giving women a more precise and reliable tool to support arousal and sensation, especially at times when their bodies may need more support." Pleasurewave contains CBD isolate and it is stabilized through Vella's proprietary biotech liposome system (LPTv1) process which works to maintain its stability over time, reflecting the company's research-driven approach to formulation. "Female arousal involves complex vascular and neurological processes," said Dr. Harin Padma-Nathan, Chief Medical Officer at Vella Bioscience. "Pleasurewave is designed to support these underlying mechanisms through targeted, localized delivery, helping enhance blood flow and sensory response where it matters most." The CBD isolate used in Pleasurewave contains no detectable THC, directly addressing common concerns around drug testing, stigma, and psychoactive effects. Vella's position is clear: intimacy should feel intentional, not tentative.

Product Overview: Pleasurewave™ Pleasurewave ($55 MSRP) is a clinical-grade arousal serum engineered with Vella's patented liposomal delivery technology, designed to support female arousal through targeted, localized application, particularly when hormonal shifts impact blood flow, tissue responsiveness, and sensation. Pleasurewave uses Vella's liposomal delivery system to encapsulate CBD isolate, enhancing skin penetration and enabling delivery to smooth muscle and nerve-dense structures within the clitoral network. This localized delivery supports vasodilation and sensory responsiveness: two important physiological components of arousal. Nano-encapsulated CBD isolate is delivered to the smooth muscle beneath the skin, a critical but often overlooked aspect of arousal. By supporting healthy blood flow and relaxing this tissue, Pleasurewave helps restore the body's natural rhythm of sensation Free from sildenafil 50 mg tab cooling agents or numbing effects, the formula includes Vitamin E to soothe sensitive skin, monk fruit extract for antioxidant support, and a clean, oil-free, microbiome-friendly base designed for compatibility with condoms, toys, and daily intimacy. In clinical studies, 90% of participants reported improvement in at least one aspect of sexual pleasure, particularly among women navigating perimenopause, menopause, stress, or other hormonal shifts. "Pleasurewave plays a central role within the broader Vella portfolio," said Joy Allen-Altimare, President of Vella Bioscience.

• Sildenafil binds to phosphodiesterase type 5 enzymes in tissues.
• It was initially developed by Pfizer.
• The drug’s patent expired in many countries, increasing generic availability.
• It can improve quality of life for men with ED and pulmonary hypertension.
• Discuss potential interactions and health conditions with your doctor.
• Usage guidelines differ for ED and pulmonary hypertension treatment.
• Follow the prescribed dose and avoid exceeding recommended limits.

"It was designed to support a critical moment in a woman's experience when desire may be present, but the body needs assistance to respond. By offering targeted, reliable arousal support, Pleasurewave helps create greater confidence, connection, and ease in intimate experiences." Vella's Pleasurewave is available at select premium retailers such as Lemon Laine, Cos Bar, Amazon and at . About Vella Bioscience, Inc.

What Are Warnings and Precautions for Sildenafil?

operations, noted in a separate interview. “Prescribers can offer an injectable form or an oral form of the same semaglutide Ozempic brand that they know of,” he said, “and consumers have flexibility and optionality between an injectable form and an oral form, and that concordance is very helpful, just from an awareness, branding and recognition perspective.”In parallel, the company is offering the new pill through some 70,000 brick-and-mortar pharmacies, and additionally, Novo is manufacturing the new Ozempic format end-to-end in the United States, largely through investments in its North Carolina operations, Millar said.With the context of supply constraints that hampered both Novo’s and Lilly’s early GLP-1 launches, Millar stressed that Novo feels “very confident in our ability to securely and reliably, dependably supply the U.S. marketplace, both with the Ozempic pill and Wegovy pill.” Rybelsus will now be discontinued as a brand across the U.S., with Ozempic pill branding and campaigns taking over. “That rebranding will be approached over the year,” Cinca said, “We will now start making more introductions for the Ozempic pill being available and for the broader brand that you can now get Ozempic as a pen or a pill.”As Novo sunsets Rybelsus, Cinca also believes this rebranding could help boost scripts of the pill. “We do anticipate this will have great resonance with our customers because we know many patients prefer a pill over a pen.

Studies of Adults with Pulmonary Arterial Hypertension

Now they can be on a branded pill that is a GLP-1, and now that is Ozempic pill.” The Wegovy brand will not change except for the addition of the Wegovy pill, announced at the start of the year, in addition to Wegovy injection. This comes amid a major new franchise in tirzepatide from Novo’s longtime rival El Lilly, a dual GIP and GLP-1 receptor agonist for diabetes and obesity under the brand names Mounjaro and Zepbound, both of which are rivaling Novo’s sales and branding iconography. Lilly also recently launched its newly approved GLP-1 drug Foundayo in the U.S., made from the ingredient orforglipron. This becomes a new direct rival for Wegovy pill.These latest changes to the Ozempic are U.S.-only: The Rybelsus branding will continue to exist outside of the country. As the drug is also being made and sold solely in the U.S. Vella Bioscience, Inc. is a female health innovator dedicated to advancing women's sexual, hormonal, and intimate wellness through rigorous science and proprietary biotechnology. Built on scientific rigor and developed by the same team behind Viagra® and Cialis®, Vella addresses critical gaps in women's health research with products designed to empower women through education and evidence-based care. The company launched the category-first Vella Pleasure Serum, giving women unprecedented agency over their sexual experiences through a science-backed, hormone-free approach. MEDIA CONTACT: [email protected] SOURCE Vella Bioscience 21% more press release views with Request a Demo Boost your research with our translational medicine data. Boost your decision using our deal data. Boost your research with our Core Patent data. Identify the latest clinical trials across global registries.

Dosages of Sildenafil

Pleasurewave is formulated using CBD isolate, a highly purified form of cannabidiol processed to remove all other cannabinoids, plant material, waxes, and terpenes, leaving behind only pure CBD. This allows Vella to formulate with greater consistency and control. "We're at a moment where women are finally being invited into the conversation around pleasure, but they're still being underserved when it comes to solutions," said Carolyn Wheeler, Co-Founder and CEO of Vella Bioscience. "Pleasurewave was created to close that gap by giving women a more precise and reliable tool to support arousal and sensation, especially at times when their bodies may need more support." Pleasurewave contains CBD isolate and it is stabilized through Vella's proprietary biotech liposome system (LPTv1) process which works to maintain its stability over time, reflecting the company's research-driven approach to formulation. "Female arousal involves complex vascular and neurological processes," said Dr.

Dosage questions

Harin Padma-Nathan, Chief Medical Officer at Vella Bioscience. "Pleasurewave is designed to support these underlying mechanisms through targeted, localized delivery, helping enhance blood flow and sensory response where it matters most." The CBD isolate used in Pleasurewave contains no detectable THC, directly addressing common concerns around drug testing, stigma, and psychoactive effects. Vella's position is clear: intimacy should feel intentional, not tentative. Product Overview: Pleasurewave™ Pleasurewave ($55 MSRP) is a clinical-grade arousal serum engineered with Vella's patented liposomal delivery technology, designed to support female arousal through targeted, localized application, particularly when hormonal shifts impact blood flow, tissue responsiveness, and sensation. Pleasurewave uses Vella's liposomal delivery system to encapsulate CBD isolate, enhancing skin penetration and enabling delivery to smooth muscle and nerve-dense structures within the clitoral network. Accelerate your research with the latest regulatory approval information.

Before Using

Empower better decisions with the latest in pharmaceutical intelligence. Sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), is a well-tolerated and highly effective treatment for erectile dysfunction. The mechanism of action of sildenafil depends on activation of the nitric oxide (NO)-cGMP pathway during sexual stimulation, which results in corpus cavernosal smooth muscle relaxation and penile erection. Endogenously derived NO is also involved in blood pressure regulation through its effect on basal vascular tone, which is mediated by cGMP levels. Organic nitrates and NO donors exert their therapeutic effects on blood pressure and vascular smooth muscle by the same mechanism as endogenous NO.

Revatio Injection

Since both sildenafil and organic nitrates exert their pharmacologic effects via increases in cGMP concentrations, a double-blind, placebo-controlled, crossover study was undertaken to investigate the effects of sildenafil coadministered with glyceryl trinitrate on blood pressure and heart rate in healthy male subjects. Understand key drug designations in just a few clicks with Synapse. Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals. Synapse data is also accessible to external entities via APIs or data packages.

Precautions with Alcohol

in this form and branding, Cinca said the message is that this is “made in America for Americans.” Rybelsus made history as the first GLP-1 drug to come in a tablet form when it was approved by the FDA in 2019. Current Rybelsus patients “should continue their medication as directed,” Novo said in a statement, but “speak with their healthcare professionals about transitioning to the Ozempic pill, as appropriate.”The changeup was first announced in February, but the new pill will officially start rolling out Monday, May 4. Grounded in female arousal physiology, Vella's hero clinical‑grade arousal serum applies a more precise, performance‑led approach to CBD in intimate wellness NEW YORK, April 14, 2026 /PRNewswire/ -- Though conversations around women's pleasure are slowly opening up, the gap between awareness and access remains. Most "solutions" designed to support the full continuum of desire, arousal, and pleasure - particularly amid hormonal change - have yet to catch up. Dialogue alone is not enough: women need real, reliable solutions that support the full continuum of desire, arousal, and pleasure.

Nonclinical Toxicology

This is where Vella Bioscience, the pioneering female health company built to address long-overlooked gaps in women's sildenafil film tablet sexual wellness, has focused its work. At the core of this mission is Pleasurewave™, Vella's first clinical-grade arousal serum, which applies a precise, biology-led approach to CBD to support the physiological realities of female pleasure. Continue Reading Vella Bioscience's Pleasurewave As CBD has become increasingly associated with intimacy, particularly among women navigating hormonal transition, Vella uses a science-led approach grounded in biological intent, formulation discipline, and transparency over trend. CBD is often discussed as a single ingredient, yet its form and composition vary widely. Full-spectrum extracts can fluctuate significantly in CBD concentration and include secondary compounds without consistent purpose. Empower better decisions with the latest in pharmaceutical intelligence. Sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), is a well-tolerated and highly effective treatment for erectile dysfunction. The mechanism of action of sildenafil depends on activation of the nitric oxide (NO)-cGMP pathway during sexual stimulation, which results in corpus cavernosal smooth muscle relaxation and penile erection. Endogenously derived NO is also involved in blood pressure regulation through its effect on basal vascular tone, which is mediated by cGMP levels. Organic nitrates and NO donors exert their therapeutic effects on blood pressure and vascular smooth muscle by the same mechanism as endogenous NO. Since both sildenafil and organic nitrates exert their pharmacologic effects via increases in cGMP concentrations, a double-blind, placebo-controlled, crossover study was undertaken to investigate the effects of sildenafil coadministered with glyceryl trinitrate on blood pressure and heart rate in healthy male subjects.